Class Review Schedule
HFS will review the following classes for the April 11, 2024 D&T Advisory Board meeting:
- Antiasthmatics-Adrenergic Combination Inhalers
- Antiasthmatics-Anticholinergic Inhalers
- Antiasthmatics-Beta Adrenergic Inhalers
- Antiasthmatics-Steroid Inhalers
All clinical and financial submissions are due to the Department by 3pm CST on March 21, 2024.
Submissions should be sent to: HFS.SupplementalRebaleProgram@illinois.gov.